跳至主要内容
临床试验/TCTR20240528003
TCTR20240528003已完成3 期

The effectiveness of 0.3% Benzydamine Hydrochloride spray in controlling pain after dental implant surgery: An open-label, double -blind, randomized clinical trial

Intramural Research Fund, Faculty of Dentistry, Chulalongkorn University0 个研究点目标入组 30 人开始时间: 2024年5月28日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

0.3% BNZD spray in minimizing reducing postoperative pain and the need of rescue analgesics following dental implant surgery. This indicates the potential of 0.3% BNZD spray as a viable option for managing pain in various clinical settings. Moreover, the favourable safety profile and ease of administration of the spray make it a practical and convenient choice for patients.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • Patients with tooth loss for at least 3 months. Bone-level submerged implants were inserted under local anesthesia without premedication.

排除标准

  • Smoking, allergy to BNZD and acetaminophen, regular use of medications affecting pain levels, need for bone or soft tissue augmentation, maxillary sinus augmentation, or pregnancy or lactation.

研究者

发起方
Intramural Research Fund, Faculty of Dentistry, Chulalongkorn University

相似试验